M&A Deal Summary

Legacy-Xspire Acquires WraSer Pharmaceuticals

On December 18, 2019, Legacy-Xspire acquired life science company WraSer Pharmaceuticals

Acquisition Highlights
  • This is Legacy-Xspire’s 3rd transaction in the Life Science sector.
  • This is Legacy-Xspire’s 3rd transaction in the United States.
  • This is Legacy-Xspire’s 3rd transaction in Mississippi.

M&A Deal Summary
Date 2019-12-18
Target WraSer Pharmaceuticals
Sector Life Science
Buyer(s) Legacy-Xspire
Deal Type Merger

Target

WraSer Pharmaceuticals

Ridgeland, Mississippi, United States
WraSer Pharmaceuticals is an emerging pharmaceutical company that identifies, develops, and markets proprietary pharmaceutical products to physicians and pharmacies throughout the United States.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Legacy-Xspire

Ridgeland, Mississippi, United States
Category Company
Founded 2019
Sector Life Science
DESCRIPTION

Legacy-Xspire market and distribute niche branded and generic prescription products to physicians, pharmacies, wholesale distributors, and specialty pharmaceutical distributors across the United States. Legacy-Xspire’s product portfolio consists primarily of therapies for pain management and steroid-responsive disease states. Legacy-Xspire is based in Ridgeland, Mississippi.

DEAL STATS #
Overall 3 of 4
Sector (Life Science) 3 of 4
Type (Merger) 3 of 3
State (Mississippi) 3 of 3
Country (United States) 3 of 4
Year (2019) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-18 Xspire Pharma

Madison, Mississippi, United States

Xspire Pharma LLC is a privately held, specialty pharmaceutical company prides itself on patient-centered, niche branded and generic pharmaceuticals that fill a void in the prescription market space. Xspire Pharma was established in 2011 and is based in Madison, Mississippi.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-03 New American Therapeutics - ZONTIVITY

Parsippany, New Jersey, United States

ZONTIVITY is a prescription medicine used to treat people who have had a heart attack or reduced blood flow in their legs (peripheral artery disease). ZONTIVITY is used with aspirin and/or clopidogrel to lower your chance of having another serious problem with your heart or blood vessels, such as heart attack, stroke, or death.

Buy -
Mergr

Product

Company

Legal